MetaCap

Progyny Earnings

NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD

27.93+0.10 (+0.36%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$0.27

Progyny earnings summary

Progyny is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $0.27. In its most recent report on Aug 6, 2026 (Q2 2026), PGNY posted EPS of $0.34. Revenue for the quarter was $350.5 million.

Quarterly EPS is up 78.9% from the same quarter a year earlier. Across the last 16 reports, PGNY shares moved an average of 5.7% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

PGNY earnings history

Progyny reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 6, 2026—$0.34—-6.5%
May 7, 2026—$0.29—-2.0%
Jan 12, 2026—$0.14—+2.9%
Nov 6, 2025—$0.15—+9.7%
Jul 8, 2025—$0.19—-5.2%
May 8, 2025—$0.17—+5.2%
Jan 13, 2025—$0.12—+5.2%
Nov 12, 2024—$0.11—+12.1%
Aug 6, 2024—$0.17—-2.6%
May 9, 2024—$0.17—+2.0%
Feb 27, 2024—$0.13—-1.5%
Nov 8, 2023—$0.16—+6.7%
Aug 4, 2023—$0.15—-9.8%
May 9, 2023—$0.18—+1.4%
Mar 1, 2023—$0.03—-15.7%
Nov 4, 2022—$0.13—-3.0%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related